OpenAlex
PricingAboutJobs
Log inGet started
Work

Aducanumab: First Approval

HTML

Year: 2021
Type: article
Source: Drugs
DOI: 10.1007/s40265-021-01569-z
Author: Sohita Dhillon
Institution: Springer Nature (New Zealand)
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: aducanumab, Alzheimer's disease, amyloid-beta, anti-amyloid monoclonal antibodies, FDA approval, drug development milestones, mild cognitive impairment, mild dementia, long-term safety and tolerability
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3185184038
FWCI: 19.21
Cites: 14
Cited by: 344
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security